Form 4: AbbVie CEO Robert A. Michael Reports Stock Transaction
SEC Form 4 Filing
AbbVie's CEO, Robert A. Michael, reports the disposition of 27,186 shares of common stock to cover tax obligations.
Summary
- On February 28, 2025, AbbVie CEO Robert A. Michael disposed of 27,186 shares of common stock.
- The transaction was executed at a price of $205.02 per share.
- This disposition was likely to cover tax obligations related to vesting equity.
- Following the transaction, Michael directly owns 132,821 shares of AbbVie common stock.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing reporting a stock transaction by an executive. It doesn't inherently convey positive or negative sentiment.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This transaction is a common occurrence where executives sell shares to cover tax obligations related to equity compensation.
Key Dates
| Date | Description |
|---|---|
| 02/28/2025 | Date of stock transaction |
| 03/04/2025 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.